PT-141 10mg

Description

PT 141 10 mg, also known as Bremelanotide, is a research grade synthetic cyclic heptapeptide derived from the Melanotan II molecular scaffold. It is studied as a melanocortin receptor agonist with preferential activity at the MC3R and MC4R receptor subtypes.

These receptors are expressed throughout the central nervous system and are widely investigated for their roles in neuroendocrine signaling, autonomic regulation, hypothalamic function, and behavioral neural pathways.

In laboratory research, PT 141 is used as a pharmacological probe for studying melanocortin receptor activity and receptor subtype contribution within central nervous system models. Researchers may employ the peptide in receptor binding assays, reporter gene studies, calcium imaging experiments, and functional signaling evaluations.

Its cyclic structure and receptor activity profile also make PT 141 useful for structure activity relationship research, receptor selectivity studies, molecular pharmacology, and comparative investigations involving other melanocortin ligands.

The 10 mg presentation is suitable for preliminary studies, concentration response testing, receptor characterization, functional assay development, and comparative neuroendocrine research.

Each PEPTEX Labs production lot is supplied as a research grade lyophilized peptide with supporting analytical documentation. Testing may include HPLC purity analysis, mass spectrometry identity verification, net content testing, and endotoxin analysis, depending on the individual batch.

This product is supplied exclusively for qualified laboratory research. It is not intended for human or veterinary use, clinical administration, or therapeutic application.